Scholars Central

CommentaryPublished 29 Oct 2025

Bioanalytical Validation: Adapting to Technology and Regulations

Authors: Oliver Jensen

Dept. of Bioanalysis, Aarhus Bio Lab, Denmark

Journal of Analytical & Bioanalytical Techniques

Volume 16 · Issue 10 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This compilation highlights contemporary advancements and challenges in bioanalytical method validation across diverse platforms and applications. It covers regulatory guidelines like ICH M10, specialized validation for LC MS MS, biomarkers, and cell based assays, and considerations for biosimilars and novel technologies such as microfluidics and dried blood spot sampling. Discussions extend to therapeutic drug monitoring, method transfer, and immunogenicity assays, emphasizing the need for robust, fit for purpose validation strategies. The overarching theme is the critical importance of ensuring method accuracy, precision, and reliability for drug development, regulatory compliance, and patient care in an evolving analytical landscape.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Analytical & Bioanalytical Techniques.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Analytical & Bioanalytical Techniques
  • SubjectBiochemistry & Biotechnology
  • SubjectChemistry
  • BylineArticles whose byline prints “Oliver Jensen”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels